The downgrade from Overweight to Equal-Weight by a major financial institution like Morgan Stanley typically indicates a less optimistic view on the stock's performance. The reduction in the price target from $14.5 to $12.5 suggests a lower expected valuation, which could lead to a negative short-term impact on the stock price.